Skip to main content

Alpha Teknova, Inc.

corporate_fare Company Profile

Alpha Teknova, Inc.

TKNO·NASDAQ·Life Sciences·CIK 0001850902

Alpha Teknova, Inc. is a leading producer of critical reagents used in the discovery, development, and commercialization of new therapies, vaccines, and molecular diagnostics. The company serves over 3,000 customers across the life sciences market, including major pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions. Teknova's business relies on its adaptable and configurable manufacturing processes and infrastructure. These proprietary processes allow the company to produce and deliver high-quality, custom, made-to-order products quickly and at scale, supporting customers through all stages of product development, including commercialization. With over two decades of expertise in raw material sourcing, chemical formulation, and quality control, Teknova can typically move a new custom product into production within weeks of receiving an order. This allows customers to receive products in weeks, compared to months from alternative suppliers. The company's processes are designed to handle diverse customer requirements, including variations in volume, chemical formulation, quality specifications, container types, and transportation needs, enabling broad application of its products across the life sciences market. Teknova offers three main product types: pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The company typically begins working with customers during the discovery phase, where they use Teknova's off-the-shelf (catalog) formulations for initial experiments.

Alpha Teknova, Inc. (NASDAQ:TKNO) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 13 items for TKNO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 8/10, with 3 rated 8 or above. Recent SEC coverage for TKNO spans 8-K, 424B5, DEF 14A, 10-K.

Recent high-impact activity:

  • Teknova Q3 Revenue Up 22% to $12.7M, Raises 2026 Revenue Guidance to $46-48M
  • Teknova Q3 Revenue Tops Estimates at $12.7M, FY Outlook In Line
  • Teknova's 8-K Confirms $40M Offering, 15% Share-Count Increase and Preliminary Q3 Beat
  • Teknova Finalizes $40M Offering at $5.00, 12% Below Pre-Deal Price
  • Teknova Prices $40M Offering at $5.00, a 12% Discount to Last Close

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$40.52M
Net Income
-$17.26M
Diluted EPS
-$0.32
Op. Cash Flow
-$8.65M
Free Cash Flow
-$9.79M
Gross Profit
$13.44M
Operating Income
-$16.98M
Cash & Equivalents
$5.91M
Total Debt
$13.12M
Debt / Equity
0.19×
Net Margin
-42.6%
Shares Outstanding
53.56M sh
Source: 10-K · filed 2026-03-02 · accession 0001850902-26-000002

Short Interest & Short Volume

1.40 days to cover

FINRA reported short interest of 1,539,570 shares in TKNO as of the October 30, 2026 settlement, a 6.7% decrease from the prior period — about 1.4 days to cover at its recent average daily volume. On November 20, 2026, 52.6% of TKNO volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,539,570 shares as of October 30, 2026
Change vs prior period▼ 6.7%
Days to cover1.40 at avg daily volume of 1,102,161
Daily short volume (FINRA facilities)52.6% of 108,023 shares on November 20, 2026
5-day average short volume49.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for TKNO, detected from its recent SEC filings · based on capital-structure filings through 2026-10-21.

1 recent capital raise

8M Shares Priced at $5.00 · Net Proceeds and Fees

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with T →
$7.63
52-week range · as of 2026-11-04 $1.91 – $9.48
Market cap
$479.95M
Volume
254.7K (0.4× avg)
3-mo avg 653.6K
Live data · 2026-11-21 05:21 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed TKNO - Latest Insights

TKNO
Nov 04, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.37
Real-time Price: $7.63 info
Change: +$0.260 (+4%) info
Market Cap: $479.951M info
TKNO
Nov 04, 2026, 4:02 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $7.37
Real-time Price: $7.63 info
Change: +$0.260 (+4%) info
Market Cap: $479.951M info
TKNO
Oct 21, 2026, 4:41 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.65
Real-time Price: $7.63 info
Change: +$1.98 (+35%) info
Market Cap: $479.951M info
TKNO
Oct 21, 2026, 4:36 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $5.81
Real-time Price: $7.63 info
Change: +$1.82 (+31%) info
Market Cap: $479.951M info
TKNO
Oct 20, 2026, 10:30 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $5.70
Real-time Price: $7.63 info
Change: +$1.93 (+34%) info
Market Cap: $479.951M info
TKNO
Oct 20, 2026, 4:06 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $6.08
Real-time Price: $7.63 info
Change: +$1.55 (+26%) info
Market Cap: $479.951M info
TKNO
Oct 20, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $6.50
Real-time Price: $7.63 info
Change: +$1.13 (+17%) info
Market Cap: $479.951M info
TKNO
May 07, 2026, 4:32 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $4.00
Real-time Price: $7.63 info
Change: +$3.63 (+91%) info
Market Cap: $479.951M info
TKNO
May 06, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.71
Real-time Price: $7.63 info
Change: +$3.92 (+106%) info
Market Cap: $479.951M info
TKNO
Apr 21, 2026, 5:22 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $3.13
Real-time Price: $7.63 info
Change: +$4.50 (+144%) info
Market Cap: $479.951M info
TKNO
Mar 02, 2026, 5:15 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.38
Real-time Price: $7.63 info
Change: +$5.25 (+221%) info
Market Cap: $479.951M info
TKNO
Mar 02, 2026, 5:10 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $2.38
Real-time Price: $7.63 info
Change: +$5.25 (+221%) info
Market Cap: $479.951M info
TKNO
Feb 26, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.28
Real-time Price: $7.63 info
Change: +$5.35 (+235%) info
Market Cap: $479.951M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets